Drugplain

CONCERTA 18 mg/1

Methylphenidate hydrochloride · TABLET, EXTENDED RELEASE · Janssen Pharmaceuticals, Inc.

No Recall HistoryCurrently in Shortage
Plain English

CONCERTA is a tablet, extended release containing methylphenidate hydrochloride at 18 mg/1, taken oral. Manufactured by Janssen Pharmaceuticals, Inc..

Key Facts

Brand Name
CONCERTA
Generic Name
Methylphenidate hydrochloride
NDC Code (Product)
50458-585
Manufacturer
Janssen Pharmaceuticals, Inc.
Strength
18 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA021121
Marketing Start
08/01/2000

Recall History

No Recall History

Frequently Asked Questions

What is CONCERTA used for?

CONCERTA contains Methylphenidate hydrochloride. It is a tablet, extended release taken oral. Consult your doctor for specific uses.

Is CONCERTA a controlled substance?

Yes, CONCERTA is classified as CII under the DEA Controlled Substances Act.

What is the generic name for CONCERTA?

The generic name for CONCERTA is Methylphenidate hydrochloride. There are 12 other brand versions of Methylphenidate hydrochloride.

What is the NDC code for CONCERTA 18 mg/1?

The NDC (National Drug Code) for CONCERTA 18 mg/1 is 50458-585, listed by Janssen Pharmaceuticals, Inc..